responder patients. This prospective comparative study, at the University of Paris XI, Assistance Publique des Hopitaux de Paris, INSERM Unit 782, was performed on 165 infertile IVF embryo transfer candidates. A total of 271 consecutive minimal stimulation IVF cycles were studied. Oocyte retrieval was performed 34 h after human chorionic gonadotrophin follicular aspiration (FA, n n = 102). The principal outcome was to evaluate clinical pregnancy and embryo implantation rates. Thus, patient characteristics, fertilization rate and clinical pregnancy rate per oocyte were comparable in both of groups. In contrast, embryo morphology (41 versus 59%, P < 0.01) and implantation rates (20.4 versus 34.8%, P < 0.04) were better in the FF group. In conclusion, an optimal reproductive
Among the possible mild stimulation protocols, the natural cycle offers many advantages. Natural cycles have been proposed as an alternative to simplify IVF treatment procedures to reduce costs and to avoid the risks of ovarian hyperstimulation and multiple pregnancies (Foulot et al., 1989; Paulson et al., 1992; Aboulghar et al., 1995; Ubaldi et al., 2005) . Improvements in methods of follicle aspiration have created a renewed interest in natural cycle and/or minimal stimulation IVF/embryo transfer and turned it into a viable option.
Poor ovarian response is observed in 9-24% (Keay et al., 1997) of patients undergoing ovarian stimulation. Many strategies of treatment have been suggested to improve the historically poor outcome of this group. Several reports have recommended that performing natural cycle IVF on these patients might be a valid alternative to egg donation and ovarian stimulation, in terms of costs and outcome (Bassil et al., 1999; Janssens et al., 2000; Morgia et al., 2004; Castelo Branco et al., 2005) . questioned by controversial data on the ovarian stimulation protocols. In fact, this procedure has been considered as Introduction useless after randomized studies showed the same oocyte anaesthesia and is a more expensive procedure (Kingsland et al., 1991; Tan et al., 1992) . Similarly, data from the literature show a reduced performance of oocytes obtained et al., 1992) and, therefore, et al., 2001) . Conversely, recent data show an increase in the practiced in ovarian stimulation protocols, with improved pregnancy and live birth rates (Bagtharia and Haloob, 2005) . stimulation IVF. This treatment is an alternative proposed for patients having a low response to ovarian stimulation (Bassil et al., 1999; Morgia et al., 2004; Castelo Branco et al., 2005) . The reproductive competence of the oocyte retrieved by IVF has become one of the most important questions because of the high frequency of failure to obtain the oocyte in the retrieval procedure, which has been reported to range from 15 to 40% (Daya et al., 1995; Bassil et al., 1999; Pelinck et al., 2002; Morgia et al., 2004) for this protocol.
Hence, this study attempted to evaluate the potential quality of eggs obtained by aspiration compared with those from
Materials and methods

Patients
This prospective study included 165 infertile women with low ovarian reserve, 20-37 years of age, undergoing 271 consecutive minimal stimulation IVF cycles from January by a previous ovarian stimulation failure and/or by a severe alteration in ovarian reserve revealed by basal hormone concentrations and on a day-3 antral follicle count by ultrasound. The previous cancellation of ovarian stimulation follicular maturation ( 16 mm) despite appropriate ovarian stimulation. A second ovarian stimulation was proposed if the basal hormone concentrations and the ultrasound for the of the following factors: antral follicle count <10 on both ovaries, FSH 10 UI/l and <15 UI/l, and/or anti-Müllerian hormone (AMH) <2 ng/ml (Fanchin et al., 1994; Frattarelli et al., 2000; Hazout et al., 2004) . A minimal stimulation IVF cycle was proposed, as better embryo implantation rates were reported with this protocol in poor responder patients (Morgia et al., 2004) and in order to optimize the IVF attempts.
The inclusion criteria were as follows: (i) both ovaries present and with no morphological abnormalities; (ii) regular menstrual cycles between 24 and 35 days; (iii) no current or past diseases affecting the ovaries or gonadotrophin or sex steroid secretion, clearance or excretion; (iv) no clinical signs of hyperandrogenism; (v) body mass index (BMI) ranging between 18 and 25 kg/m 2 ; (vi) no current hormone therapy; and (vii) adequate visualization of both ovaries on transvaginal ultrasound scans. The causes of infertility were male factor (45.9%), unexplained infertility (24%), tubal abnormalities (21.6%) and endometriosis (8.5%). An informed consent was obtained from all patients and this investigation received the approval of the internal Institutional Review Board.
IVF/embryo transfer protocol
On cycle day 3, all patients underwent blood sampling by venipuncture at approximately 9 a.m. for serum oestradiol, progesterone, FSH and LH measurements. Later in the morning, the number and the sizes of early antral follicles were assessed by ultrasound equipped with a tissue harmonic imaging system (Thomas and Rubin, 1998) . From cycle day 8 onward, the selection of the dominant follicle was monitored by ultrasound and by serum oestradiol concentrations. When the mean diameter of the dominant follicle exceeded 12 mm, to prevent the risk of premature LH peak and to control further follicular maturation, 0.5 mg gonadotrophinreleasing hormone antagonist (cetrorelix acetate; Cetrotide 0.25 mg, Serono Pharmaceuticals, Boulogne, France) and 150 IU human menopausal gonadotrophin (Menopur, Ferring Pharmaceuticals, Gentilly, France) were administered subcutaneously daily until the day of human chorionic gonadotrophin (HCG; Gonadotrophine Chorionique 'Endo', Organon Pharmaceuticals, Saint-Denis, France) administration. Finally, women received a 5000 IU HCG injection intramuscularly when the diameter of the dominant follicle exceeded 16 mm (Dubey et al., 1995; Bergh et al., 1998) .
Follicular aspiration and follicular flushing
Oocyte retrieval was performed 34 h after HCG administration. This time was chosen, rather than 36 h, to avoid the risk of possible follicular rupture before aspiration. Under the single preovulatory follicle was aspirated using a single channel 16 gauge needle attached to a 10 ml syringe. The aspiration needle was kept steady inside the follicle until the oocyte was found and isolated. These oocytes were entered in the follicular aspiration (FA) group.
In case of negative oocyte recovery, sequential follicular 3 ml of a balanced saline solution (Tyrode's salt solution, Eurobio Pharmaceuticals, Courtaboeuf, France) pre-warmed to 37° (FF) group.
Intracytoplasmic sperm injection was used only in the presence of male factor infertility (<0.3 10 6 /ml motile blastomeres, and less than 20% anucleated fragments (Van Royen et al., 1999) . Embryo transfer was performed 2 days after oocyte retrieval using a classic Frydman catheter (CCD laboratories, Paris, France) guided by abdominal ultrasound (Voluson 730 Expert; General Electric Medical Systems, abdominal probe AB2-7 of 2-7 Mhz); so allowing embryo release to be positioned at 1.5 to 2 cm from the uterine fundus. The luteal phase was supported with 600 mg/day micronized progesterone (Estima Gé èvres, France) administered daily by vaginal route starting on the evening of embryo transfer.
Analysis of groups
The FA and FF groups were analysed by comparing the prevalence of oocytes with fractured zona pellucida, the fertilization rate, the prevalence of top quality embryos (A and B from the Van Royen et al. the implantation rate and clinical pregnancy rate per oocyte.
Hormonal measurements
Serum FSH, oestradiol and progesterone concentrations were determined by an automated multi-analysis system using a chemiluminescence technique (Advia-Centaur, Bayer Diagnostics, Puteaux, France). For FSH, the lower detection of variation were 3 and 5%, respectively. For oestradiol, the lower detection limit was 15 pg/ml, linearity up to 1,000 pg/ and 9%, respectively. For progesterone, lower detection limit was 0.1 ng/ml, linearity up to 60 ng/ml, and intra-and inter-Serum LH concentrations were measured by an immunometric technique using an Amerlite kit (Ortho Clinical Diagnostics, Strasbourg, France). Lower limit of detection was 0.1 mIU/ and 7%, respectively for LH.
Statistical analysis
The measures of central tendency and variability used were, respectively, the mean and SD when data distribution was normal, and the median and the ranges when normality could not be ascertained. Normal distribution of the data was assessed with the Kolmogorov Smirnov test. Unpaired data were compared with the unpaired Student's t-test or the Mann-Whitney test, as appropriate. The relationship between two continuous variables was assessed by correlation when they were independent from each other and by simple regression when there was a dependency relationship. The chi-squared and Fisher's exact test were used to compare categorical variables. The present study was powered to detect anticipated differences of 25% in embryo implantation observations were the basis for calculating the population according to the oocyte retrieval rate, fertilization rate and embryo development rate. A P-value of < 0.05 was considered
Results
Patient characteristics and cycle monitoring data
The oocyte retrieval procedure was performed in 271 IVF/ embryo transfer cycles, and oocytes were recovered in 229 underwent two cycles, and 37 patients underwent three cycles. From the oocytes recovered, 127 were retrieved from eventually one oocyte, per cycle was aspirated because GnRH antagonist and exogenous FSH were administered if there was a follicular size of 14 mm: co-dominant follicles were not observed.
Patient characteristics and cycle monitoring data in the FA and FF groups are detailed in Table 1 . The age of patients, their BMI values, menstrual cycle lengths and antral follicle counts on day 3 were comparable in both of groups. Serum FSH concentration on day 3 of the current treatment cycle was obtained for most, but not all, of the patients (n = 240): 7.8 ± 2.6 and 8.1 ± 2.7 mIU/ml for FA and FF groups, respectively. Aetiologies of infertility were also similar in the two groups. Moreover, the day of HCG administration and preovulatory follicle size, endometrial thickness and ceoncentration of serum oestradiol, progesterone and LH on the day of HCG were not statistically different between two groups.
Embryology and IVF/embryo transfer outcome data
Embryology data and IVF/embryo transfer outcome data are summarized in Table 2 . Both groups of oocytes remained similar with regard to prevalence of fractured zona pellucida, fertilization rates and clinical pregnancy rates/oocyte (gestational sac observed via ultrasound scans at around 7 weeks of amenorrhoea). Conversely, the prevalence of top quality embryos and the implantation rates (total number of gestational sacs x 100/total number of embryos transferred) P < 0.01, and 20.4 versus 34.8, P < 0.04, respectively).
Discussion
patients and the reproductive competence of oocytes issued from this technique. For this, its design required the following methodological characteristics. First, IVF/embryo transfer consecutive cycles over 2 years were included to avoid bias. Second, the single follicle cycles allowed proper tracking of the assessment of oocytes according to origin, the oocytes were accurately separated into two groups, FA and FF, following retrieval.
This study observed a notably quantitative increment in oocyte recovery rate between that expected with follicular aspiration (84.6%). Nevertheless, these results differ from previous studies on ovarian stimulation (Kingsland et al., 1991; was observed in 15.5% of oocyte retrieval attempts. The causes of non-retrieval remain unknown, even when technical loss, early ovulation, lack of cumulus-oocyte expansion or empty follicle syndrome are taken into consideration (Lok et al., 2003; Uygur et al., 2003; Bustillo, 2004; Kourtis et al., 2004; Vujisic et al., 2005) .
In addition, the results of this investigation indicated that, in poor responder patients, the oocytes retrieved 34 h post HCG quality and implantation outcome for the corresponding embryo underlying this relationship remain unclear. It is possible that reaction to HCG (Bomsel-Helmreich et al., 1987) and could be overmatured compared with those secondarily retrieved. Also, contact with cumulus cells (Goud et al., 1998) ; however, this data contrast with poor quality oocytes reported in previous studies on ovarian stimulation (el Hussein et al., 1992; Knight et al., 2001) . These differences can be partially explained by the lower exposure to FSH, the oocyte retrieval timing (36 versus 34 h after HCG administration) and a possible atypical cumulus-oocyte relationship in poor responder patients.
improve the oocyte retrieval rate in minimal stimulation IVF for poor responder patients. Also, oocytes obtained by follicular retrieval present a high reproductive competence as observed by the embryo implantation rates. However, cumulus-oocyte dependence in patients with a low ovarian reserve should be a matter of additional investigation.
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